Drug Shortage Report for QUETIAPINE XR
Report ID | 216838 |
Drug Identification Number | 02519623 |
Brand name | QUETIAPINE XR |
Common or Proper name | Quetiapine Fumarate Extended-Release Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 200MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-19 |
Estimated end date | 2024-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-03-12 | French | Compare |
v3 | 2024-03-12 | English | Compare |
v2 | 2024-01-20 | French | Compare |
v1 | 2024-01-20 | English | Compare |
Showing 1 to 4 of 4